>>
Industry>>
Healthcare>>
US and J&J Eye to Produce ...US and J&J Eye to Produce Single-Dose COVID-19 Shot in India
The Silicon Review
12 May, 2021
Author:
The Silicon Review Team
The US is planning to jointly produce COVID-19 vaccines in partnership with the Johnson & Johnson in India. This will help Indian manufacturers such as the Serum Institute of India (SII) ramp up production to meet vaccine needs around the globe. Earlier, the White House said that the US plans to share 60 million doses of AstraZeneca's vaccine globally.
Now the US is showing concern towards the current course of the pandemic in India, not just because of the humanitarian catastrophe but also due to the fact that it has global implications, noting that the Biden administration was standing with New Delhi to help deal with the crisis. Also, India's role in the production of Covid-19 vaccines at the global stage is critical.
Recent reports have stated that the US has been in touch with multiple vaccine manufacturers in the country. As India faced a devastating second wave of coronavirus infections, the US rapidly deployed six planeloads of life-saving supplies in support of the country's fight against the pandemic. The US government's assistance to India is estimated at $100 million.
